Amesite director buys shares and long-dated warrants
Amesite Inc. director George Parmer reported a net purchase of Amesite securities.
Rhea-AI Filing Summary
Amesite Inc. director George Parmer reported a net purchase of Amesite securities. He bought 243,902 shares of Common Stock at $1.435 per share in a private placement pursuant to a securities purchase agreement. Following this, he directly holds 566,962 Common shares.
Parmer also acquired 243,902 Series A-2 Warrants and 243,902 Series A-1 Warrants, each giving the right to buy Common Stock at an exercise price of $1.435 per share. The Series A-2 Warrants expire on October 28, 2027, and the Series A-1 Warrants expire on April 28, 2031. These transactions were made in connection with the same private placement offering described in an Amesite 424(b)(5) prospectus supplement.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 731,706 shares
Net Buy
3 txns
Insider
Parmer George
Role
Director
Bought
731,706 shs ($350K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Series A-1 Warrants (right to buy) | 243,902 | $0.00 | $0.00 |
| Purchase | Series A-2 Warrants (right to buy) | 243,902 | $0.00 | $0.00 |
| Purchase | Common Stock | 243,902 | $1.435 | $350K |
Holdings After Transaction:
Series A-1 Warrants (right to buy) — 243,902 contracts (Direct);
Series A-2 Warrants (right to buy) — 243,902 contracts (Direct);
Common Stock — 566,962 shares (Direct)
Footnotes (1)
- F1. The shares were purchased in a private placement transaction pursuant to a securities purchase agreement. For more information relating to the offering pursuant to which the reported shares were purchased, please refer to the 424(b)(5) prospectus supplement filed by Amesite Inc. with the SEC on April 28, 2026.
Key Figures
Common shares purchased: 243,902 shares
Purchase price per share: $1.435 per share
Common shares held after: 566,962 shares
+5 more
8 metrics
Common shares purchased
243,902 shares
Common Stock bought on April 28, 2026
Purchase price per share
$1.435 per share
Price for Common Stock in private placement
Common shares held after
566,962 shares
Direct Common Stock ownership after transaction
Series A-2 Warrants acquired
243,902 warrants
Right to buy Common Stock at $1.435
Series A-1 Warrants acquired
243,902 warrants
Right to buy Common Stock at $1.435
Series A-2 Warrant expiration
October 28, 2027
Expiration date for Series A-2 Warrants
Series A-1 Warrant expiration
April 28, 2031
Expiration date for Series A-1 Warrants
Total securities bought (Form 4 summary)
731,706 shares
Net buy across Common and warrant-related shares
Key Terms
private placement, securities purchase agreement, 424(b)(5) prospectus supplement, Series A-2 Warrants, +2 more
6 terms
private placement financial
"The shares were purchased in a private placement transaction pursuant to a securities purchase agreement."
A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.
securities purchase agreement financial
"The shares were purchased in a private placement transaction pursuant to a securities purchase agreement."
A securities purchase agreement is a written contract between a buyer and a seller outlining the terms for buying or selling financial assets such as stocks or bonds. It specifies details like the price, quantity, and conditions of the transaction, similar to a shopping list with agreed-upon terms. For investors, it provides clarity and legal protection when transferring ownership of these financial instruments.
424(b)(5) prospectus supplement regulatory
"please refer to the 424(b)(5) prospectus supplement filed by Amesite Inc. with the SEC on April 28, 2026."
Series A-2 Warrants financial
"Series A-2 Warrants (right to buy) ... underlying security title: Common Stock"
Series A-2 warrants are a specific class of long‑term options issued by a company that give the holder the right to buy a set number of shares at a pre‑agreed price. Think of them as a coupon for future stock purchases: they can add potential value for the holder if the share price rises, but they also represent potential dilution for existing shareholders and can affect an investor’s ownership and returns when exercised or converted.
Series A-1 Warrants financial
"Series A-1 Warrants (right to buy) ... underlying security title: Common Stock"
Series A-1 warrants are tradable instruments that give their holder the right, but not the obligation, to buy a company’s shares at a preset price for a limited time; they are typically issued alongside a specific financing round labeled “Series A-1.” Think of them like a coupon that lets an investor buy stock at a locked-in price later — if the company’s share price rises above that price the coupon becomes valuable, otherwise it may expire worthless. For investors they matter because exercising warrants can increase potential upside while also diluting existing shareholders and affecting future ownership percentages and share value.
open-market purchase financial
"transaction_action: open-market purchase; transaction_code_description: Purchase in open market or private transaction"
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Amesite (AMST) director George Parmer buy in this Form 4 filing?
George Parmer bought Common Stock and related warrants in Amesite. He purchased 243,902 Common shares at $1.435 per share and received matching Series A-1 and A-2 Warrants for 243,902 underlying shares each in a private placement transaction.
What are the key terms of the Amesite (AMST) Series A-1 and A-2 Warrants?
Parmer acquired 243,902 Series A-1 and 243,902 Series A-2 Warrants, each exercisable for Common Stock at $1.435 per share. The Series A-2 Warrants expire on October 28, 2027, while the Series A-1 Warrants have a longer term, expiring on April 28, 2031.
Was the Amesite (AMST) insider purchase an open-market trade or private placement?
The purchase occurred in a private placement transaction under a securities purchase agreement. The footnote explains the shares and warrants were acquired in an offering described in Amesite’s 424(b)(5) prospectus supplement filed with the SEC on April 28, 2026.
How many Amesite (AMST) securities did George Parmer buy in total?
Across Common Stock and warrants, the Form 4 shows net purchases of 731,706 Amesite-related securities. This includes 243,902 Common shares plus 243,902 underlying shares for each of the Series A-1 and Series A-2 Warrants acquired in the private placement.
AI-generated analysis. How Rhea-AI works. Not financial advice.
